Mark W Russell

13PUBLICATIONS
124CO-AUTHORS
Medical devicesCardiology (incl. cardiovascular diseases)Characterisation of biological macromolecules
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (13)

|Oct 10, 2026
Body Mass Index, Valsartan, and Myocardial Remodeling in Early-Stage Hypertrophic Cardiomyopathy: A Secondary Analysis of the Randomized VANISH Trial.

|Apr 17, 2026
The Natural History of Massive Left Ventricular Hypertrophy in Pediatric Hypertrophic Cardiomyopathy: A Multiregistry Analysis.

|May 09, 2025
Proteomic Analysis of Valsartan for Attenuating Disease Evolution in Early Sarcomeric Hypertrophic Cardiomyopathy (VANISH) Clinical Trial.

Constantin-Cristian Topriceanu, Christoffer Rasmus Vissing, Anna Axelsson Raja

|Mar 26, 2025
Methylated Arginine Metabolites as Biomarkers for Clinical Status and Response to Type 5 Phosphodiesterase Inhibition in Patients With Fontan Circulation.

Ari Cedars, Cedric Manlhiot, Bhargava Kumar Chinni

|Dec 05, 2024
Low Penetrance Sarcomere Variants Contribute to Additive Risk in Hypertrophic Cardiomyopathy.

Joshua K Meisner, Aaron Renberg, Eric D Smith

|Aug 01, 2024
Quality of Life and Exercise Capacity in Early Stage and Subclinical Hypertrophic Cardiomyopathy: A Secondary Analysis of the VANISH Trial.

Catherine G Ireland, Danielle S Burstein, Sharlene M Day

Pageof 3

Frequent Collaborators

8 joint publications

Sharlene M Day

8 joint publications

Joseph W Rossano

7 joint publications

Anjali T Owens

6 joint publications

Neal K Lakdawala